secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2022-04-20T23:59:59+00:00
Accession:  0001104659-22-047904
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two Voyager directors request not to be renominated; search for replacements underway
--------------------------------------------------------------------------------

- Mark Levin and Steven Paul, M.D. will not stand for re-election at 2022 annual meeting.
- Both directors cited desire to reduce professional commitments and board seats.
- Departures not due to any disagreement with board or management.
- Nominating committee has engaged search firm to fill anticipated vacancies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/0001104659-22-047904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/tm2213132d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-047904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer